Nivolumab safety in patients with advanced melanoma who have progressed on or after Ipilimumab : a single-arm, open-label, multicenter, phase II study (CheckMate 172)

Ascierto P.A.; Demidov, L.; Garbe, C.; Lorigan, P.; Gogas, H.; Hoeller, Ch.; Haanen, J.; Espinosa, E.; Guren, T.; Munoz-Couselo, E.; RORIVE, Andrée; Rutkowski, P.; Dummer, R.; Carneiro, A.; Hospers, G.; Hermann, F.; Jiang, J.; Schadendorf, D.; Nathan, P.

Paper published in a journal (Scientific congresses and symposiums)

Ascierto P.A.; Demidov, L.; Garbe, C. et al.

2016 • In Journal of Clinical Oncology, 34, p. 9526

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/220962

Files (2)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Nivolumab safety in patients with advanced melanoma ... - abstract.pdf

Publisher postprint (722.94 kB)

Request a copy

Annexes

Nivolumab safety in patients with advanced melanoma ... - poster.pdf

Publisher postprint (129.9 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

oncology

Disciplines :

Oncology

Author, co-author :

Ascierto P.A.

Demidov, L.

Garbe, C.

Lorigan, P.

Gogas, H.

Hoeller, Ch.

Haanen, J.

Espinosa, E.

Guren, T.

Munoz-Couselo, E.

More authors (9 more)

Language :

English

Title :

Nivolumab safety in patients with advanced melanoma who have progressed on or after Ipilimumab : a single-arm, open-label, multicenter, phase II study (CheckMate 172)

Publication date :

2016

Event name :

2016 ASCO Annual Meeting

Event place :

Chicago, United States

Event date :

June 3-7, 2016

Audience :

International

Journal title :

Journal of Clinical Oncology

ISSN :

0732-183X

eISSN :

1527-7755

Publisher :

American Society of Clinical Oncology, Alexandria, United States - Virginia

Volume :

Pages :

abstract 9526

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 02 March 2018

Statistics

Number of views

43 (2 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics